|
| Drug Discovery and Production | |
| The latest drug discovery news from News Medical | |
|
|
| Web-based Barcode Scanner Technology
In modern laboratories - samples are typically stored in large -80°C freezers, liquid nitrogen tanks or fully automated stores that are often inconveniently situated in an outbuilding or a basement. Datapaq 5 from Ziath is the first of a new generation of digital sample management tools that allows sample management technicians to quickly and accurately log sample identity at the point of storage or retrieval. Datapaq 5 offers a convenient way to use a 2D barcoded tube or rack scanner anywhere across a laboratory or an organisation’s site where a suitable laptop or computer is available. Running from any computer on a local network or over the internet if your IT rules allow, Datapaq 5 uses a web-based graphical user interface to provide visual confirmation of tube identity and individual tube image inspection. The new web-based software includes a host of features designed to streamline the collection of tube information for subsequent processing in inventory management software.
| |
|
|
|
|
|
| Molecular Imaging in Drug Development While healthcare has made significant advancements over the last century, and medical professionals are more equipped than ever with the tools to treat a whole range of illnesses, the landscape of healthcare continues to evolve, and with this ever-changing environment comes the continued need for new drug candidates | |
|
| CRISPR-edited immune cells can be safely given to cancer patients The emergence of CRISPR-Cas9 gene-editing technology has spurred hope in both doctors and patients since it shows promise in treating a multitude of diseases, including cancer. For the first time in the United States, a team of scientists has shown that CRISPR-edited immune cells can be safely used to cancer patients. | |
|
| The research and development costs of a new drug Many recent studies have focused on how much it costs to bring a new drug to market in the light of increasing drug prices. Estimates range from $314 million to $2.8 billion. Most of this was based on proprietary data and was, therefore, not verifiable independently, attracting much criticism. | |
|
|
|
|
No hay comentarios:
Publicar un comentario